A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Clinical trial NCT07201922 · RECRUITING

Trial details

NCT number: NCT07201922
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Familial Pulmonary Fibrosis Interstitial Lung Abnormalities Interstitial Lung Diseases

Start date: 2026-02-10
Primary completion: 2029-05-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.